Researcher
Patrick Neven
- Disciplines:Gynaecology and obstetrics, Nursing, Endocrinology and metabolic diseases
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 13
- Early folliculogenesis and ovarian aging in women with genetic predisposition to (breast)cancerFrom15 Jul 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Effectiveness of an eHealth self-management support program for persistent pain after breast cancer treatmentFrom1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- breastcancer and sexualityFrom25 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Epidemiological study of relapse in breast, ovarian and cervical cancers.From1 Oct 2018 → 30 Sep 2021Funding: Nonprofit institution or equivalents
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Key biological processes involved in breast cancer invasion and metastases leading to residual disease after local therapy of breast tumors.From1 Jul 2014 → 30 Jun 2018Funding: Private funding of national origin - undefined
- Assessment of market access policies and instruments for oncology drugs.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 572
- Biologic profile to predict overall survival in non-metastatic breast cancer: A latent class analysis on aging biomarkers(2023)
Authors: Cindy Kenis, Patrick Neven, Sigrid Hatse, Hans Wildiers
- Capturing age-related changes in the tumor microenvironment of luminal breast cancer using the multiplex immunohistochemistry technique, MILAN.(2023)
Authors: Yentl Lambrechts, Maxim De Schepper, Tatjana Geukens, Hanne Vos, Julie Messiaen, Patrick Neven, Christine Desmedt, Francesca Bosisio, Frederik De Smet, Sigrid Hatse, et al.
- Alpelisib plus endocrine therapy in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Analysis of all 3 cohorts of the BYLieve study(2023)
Authors: Patrick Neven
- Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data(2023)
Authors: Hava Izci, Hans Wildiers, Patrick Neven
Pages: 559 - 568 - Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study(2023)
Authors: Eva Oldenburger, Albert Wolthuis, Els Van Nieuwenhuysen, Patrick Neven, Ignace Vergote, Sileny Han
Pages: 1539 - 1545 - Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade(2023)
Authors: Johanna Jacobs, Caroline Weltens, Jens-Uwe Voigt, Hans Wildiers, Patrick Neven, Jan A Staessen, Lucas Van Aelst
- Genomic characterisation of hormone receptor-positive breast cancer arising in very young women(2023)
Authors: Patrick Neven
Pages: 397 - 409 - Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?(2023)
Authors: Karen Van Baelen, Christine Desmedt, Hans Wildiers, Patrick Neven
Pages: 269 - Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer (vol 33, pg 769, 2022)(2023)
Authors: François Richard, Chantal Van Ongeval, Maxim De Schepper, Ann Smeets, Hans Wildiers, Patrick Neven, Christine Desmedt
Pages: 326 - 326 - Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER plus ) breast cancer: a retrospective analysis of the SOLE trial(2023)
Authors: François Richard, Beppe Floris, Patrick Neven, Christine Desmedt